Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Immunomodulation and AD--down but not out.

Knight EM, Gandy S.

J Clin Immunol. 2014 Jul;34 Suppl 1:S70-3. doi: 10.1007/s10875-014-0039-y. Epub 2014 Apr 30. Review.

PMID:
24781637
2.

Clinical trials of intravenous immunoglobulin for Alzheimer's disease.

Relkin N.

J Clin Immunol. 2014 Jul;34 Suppl 1:S74-9. doi: 10.1007/s10875-014-0041-4. Epub 2014 Apr 24. Review.

PMID:
24760112
3.

Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.

Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A, Greco A, Seripa D, Pilotto A.

Immunotherapy. 2012 Feb;4(2):213-38. doi: 10.2217/imt.11.170. Review.

PMID:
22339463
4.

Intravenous immunoglobulins for Alzheimer's disease.

Puli L, Tanila H, Relkin N.

Curr Alzheimer Res. 2014;11(7):626-36. Review.

PMID:
25115546
5.

Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.

Hashimoto T, Serrano-Pozo A, Hori Y, Adams KW, Takeda S, Banerji AO, Mitani A, Joyner D, Thyssen DH, Bacskai BJ, Frosch MP, Spires-Jones TL, Finn MB, Holtzman DM, Hyman BT.

J Neurosci. 2012 Oct 24;32(43):15181-92. doi: 10.1523/JNEUROSCI.1542-12.2012.

6.

Immunotherapy for Alzheimer's disease.

Steinitz M.

Immunotherapy. 2009 May;1(3):461-9. doi: 10.2217/imt.09.3.

PMID:
20635962
7.

Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease.

Panza F, Frisardi V, Imbimbo BP, D'Onofrio G, Pietrarossa G, Seripa D, Pilotto A, Solfrizzi V.

Immunotherapy. 2010 Nov;2(6):767-82. doi: 10.2217/imt.10.80. Review.

PMID:
21091109
8.

Intravenous immunoglobulins as a treatment for Alzheimer's disease: rationale and current evidence.

Dodel R, Neff F, Noelker C, Pul R, Du Y, Bacher M, Oertel W.

Drugs. 2010 Mar 26;70(5):513-28. doi: 10.2165/11533070-000000000-00000. Review.

PMID:
20329802
9.

Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease.

Magga J, Puli L, Pihlaja R, Kanninen K, Neulamaa S, Malm T, Härtig W, Grosche J, Goldsteins G, Tanila H, Koistinaho J, Koistinaho M.

J Neuroinflammation. 2010 Dec 7;7:90. doi: 10.1186/1742-2094-7-90.

10.

Overview of immunotherapy in Alzheimer's disease (AD) and mechanisms of IVIG neuroprotection in preclinical models of AD.

Counts SE, Lahiri DK.

Curr Alzheimer Res. 2014;11(7):623-5. No abstract available.

PMID:
25156573
11.

Intravenous immunoglobulin and Alzheimer's disease immunotherapy.

Solomon B.

Curr Opin Mol Ther. 2007 Feb;9(1):79-85. Review.

PMID:
17330405
12.

[Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps].

Kuzuhara S.

Brain Nerve. 2010 Jul;62(7):659-66. Review. Japanese.

PMID:
20675870
13.

Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward.

Panza F, Solfrizzi V, Imbimbo BP, Tortelli R, Santamato A, Logroscino G.

Expert Rev Clin Immunol. 2014 Mar;10(3):405-19. doi: 10.1586/1744666X.2014.883921. Epub 2014 Feb 4. Review.

PMID:
24490853
14.

Immunotherapy for Alzheimer's disease: rational basis in ongoing clinical trials.

Menéndez-González M, Pérez-Piñera P, Martínez-Rivera M, Muñiz AL, Vega JA.

Curr Pharm Des. 2011;17(5):508-20. Review.

PMID:
21375481
15.

Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.

Geylis V, Steinitz M.

Autoimmun Rev. 2006 Jan;5(1):33-9. Epub 2005 Aug 1. Review.

PMID:
16338209
16.

Naturally occurring autoantibodies against β-Amyloid.

Bach JP, Dodel R.

Adv Exp Med Biol. 2012;750:91-9. doi: 10.1007/978-1-4614-3461-0_7. Review.

PMID:
22903668
17.

Efficacy of antibody-based therapies to treat Alzheimer's disease: just a matter of timing?

Cedernaes J, Schiöth HB, Benedict C.

Exp Gerontol. 2014 Sep;57:104-6. doi: 10.1016/j.exger.2014.05.002. Epub 2014 May 14.

PMID:
24835192
18.

A phase 3 trial of IV immunoglobulin for Alzheimer disease.

Relkin NR, Thomas RG, Rissman RA, Brewer JB, Rafii MS, van Dyck CH, Jack CR, Sano M, Knopman DS, Raman R, Szabo P, Gelmont DM, Fritsch S, Aisen PS; Alzheimer's Disease Cooperative Study.

Neurology. 2017 May 2;88(18):1768-1775. doi: 10.1212/WNL.0000000000003904. Epub 2017 Apr 5.

PMID:
28381506
19.

Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?

Panza F, Logroscino G, Imbimbo BP, Solfrizzi V.

Curr Opin Psychiatry. 2014 Mar;27(2):128-37. doi: 10.1097/YCO.0000000000000041. Review.

PMID:
24445401
20.

Vaccines: chasing the dream.

Schnabel J.

Nature. 2011 Jul 13;475(7355):S18-9. doi: 10.1038/475S18a. No abstract available.

PMID:
21760578

Supplemental Content

Support Center